Polymotion® IDE Study Reaches 30% Enrollment Milestone
23 Jun 2025
Momentum Builds as Polymotion® Hip Resurfacing IDE Study Reaches 30% Enrolment and Expands to Nine Active Sites in the US.
We are pleased to announce that the Polymotion® Hip Resurfacing (PHR®) IDE study has now reached 30% of its target enrolment. This reflects the strong momentum behind the study and mission to bring this next-generation hip resurfacing technology to patients in the United States.
In line with this momentum, we’ve also